Impact of Socio-Economic Status in the Selection of Pharaceutical Brand


Authors : DR. SHAFI’I ABDULLAHI MA’ALIM MOHAMED; DR. SAIF-UR-REHMAN KHATTAK

Volume/Issue : Volume 5 - 2020, Issue 9 - September

Google Scholar : http://bitly.ws/9nMw

Scribd : https://bit.ly/3waxCyL

Socio- economic status plays an important role in every walk of life. Its impact ranges from very small scale to very large scale. This research considers how socio-economic status of the society affects the prescribers and the customers in selection of pharmaceutical brands. The data is collected from the physicians and pharmacist whom we selected for our research study by asking open ended questions and filling the questionnaire with the answers of the entire relevant questions related to socioeconomic status. From our result it is evaluated that physicians normally take into account the socioeconomic status of the patients while prescribing medicines for them. For example mostly doctors prescribe generic Omeprazole brand Risek 68%. People of different socio-economic classes use this brand due to various reasons. Low and middle class people buy this as physicians prescribe to them. The reason of prescribing is its availability and quality. While upper class purchase this due to its quality. While most prescribed brand in the generic Salbutamol is Ventoline 68%. People of different socio-economic classes use this brand due to various reasons. Low and middle class people buy this as physicians prescribe to them. And the reason of prescribing is also its availability and it is not that much expensive. While upper class purchase this due to its quality.

CALL FOR PAPERS


Paper Submission Last Date
30 - September - 2021

Paper Review Notification
In 1-2 Days

Paper Publishing
In 2-3 Days

Never miss an update from Papermashup

Get notified about the latest tutorials and downloads.

Subscribe by Email

Get alerts directly into your inbox after each post and stay updated.
Subscribe
OR

Subscribe by RSS

Add our RSS to your feedreader to get regular updates from us.
Subscribe